No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Spurs Sports and Entertainment and Canon Medical Partnership To Benefit High-Performance Athletes and Weekend Warriors

Editor: What To Know

  • As part of the partnership, Canon Medical and the Spurs will collaborate on advancing medical imaging innovation to benefit everyone from high-performance athletes to weekend warriors and beyond.
  • The collaboration between Canon Medical and SS&E began in 2016 after Buford and a group of Spurs executives visited Ciutat Esportiva Joan Gamper, the training complex for FC Barcelona.
  • Since then, the Spurs identified Canon Medical as a critical part of their player care program and have been participating in Canon Medical's professional education programs.

Spurs Sports and Entertainment: announced today a new partnership between Canon Medical Systems USA, Inc. and the San Antonio Spurs.

Spurs Sports and Entertainment is the premier provider of sports and entertainment in South Texas. They owns and operate the San Antonio Spurs, Austin Spurs (NBA G League), San Antonio FC (USL) and also manages the day-to-day operations of the AT&T Center and Toyota Field.

As part of the partnership, Canon Medical and the Spurs will collaborate on advancing medical imaging innovation to benefit everyone from high-performance athletes to weekend warriors and beyond.

“The Spurs are thrilled to partner with Canon Medical because they believe in using their technology to better humanity,” said RC Buford, CEO of Spurs Sports & Entertainment.  “We want to work with curious companies who have a learner mindset and are willing to bring new ideas forward. With a focus on today, we are always planning for tomorrow, and we believe this relationship will help us compete at the highest level.”

The collaboration between Canon Medical and SS&E began in 2016 after Buford and a group of Spurs executives visited Ciutat Esportiva Joan Gamper, the training complex for FC Barcelona.  In his visit, Buford learned how Canon Medical was at the forefront of diagnostic imaging. Since then, the Spurs identified Canon Medical as a critical part of their player care program and have been participating in Canon Medical’s professional education programs.

“At Canon Medical, our ‘Made For Life’ philosophy drives us to deliver innovative solutions to improve the quality of life for all people,” said Yuji Hamada, CEO of Canon Medical Systems USA, Inc. “The San Antonio Spurs embody that belief, which makes them an ideal partner. As the Spurs continue to perform as one of the highest-level teams in U.S. professional sports, it is our goal to work with the best clubs in the U.S. and globally so that we can take what we learn from elite athletes and apply it to all people.”

Additional information about the partnership will be highlighted through the Spurs social channels in the coming months.  Click here to watch a video on the partnership.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy